UP

FDA: Pfizer vaccine 90.7% effective in kids aged 5-11

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto
FDA: Pfizer vaccine 90.7% effective in kids aged 5-11

The United States Food and Drug Administration (FDA) revealed on Friday its latest study found Pfizer Inc. and BioNTech SE's vaccine against COVID-19 is 90.7% effective against the disease in children aged between five and 11.

Axar.az reports that the trials were conducted in 2,268 individuals divided into two groups. Those that received both doses of the jab developed an immunity of 90.7% in comparison to those that got a placebo.

Pfizer asked for the FDA's approval for the use of its treatment in kids earlier this month.

Date
2021.10.22 / 20:31
Author
Axar.az
See also

WHO says low risk of Nipah virus spreading beyond India

Asian countries step up airport checks over Nipah virus

Deadly Nipah virus cases reported in India

Robots get human-like “Smart Skin”

WHO warns of rapid spread of "Hong Kong Flu"

Japanese frog bacteria kill cancer cells

Stem cell drug offers non-opioid osteoarthritis pain relief

US develops AI tool for early breast cancer detection

Red meat increases stroke risk in older adults

Avoid alcohol in autumn to protect your immunity

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla